In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4+ T cell loss

被引:21
|
作者
Watkins, Richard L. [1 ]
Foster, John L. [1 ]
Garcia, J. Victor [1 ]
机构
[1] Univ N Carolina, Div Infect Dis, UNC Ctr AIDS Res, Genet Med, Chapel Hill, NC 27599 USA
来源
RETROVIROLOGY | 2015年 / 12卷
基金
美国国家卫生研究院;
关键词
HIV-1; Nef; Replication; Pathogenesis; IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN LYMPHOID-TISSUE; HUMANIZED BLT MICE; EX-VIVO; DISEASE PROGRESSION; IMMUNE EVASION; HOST-CELL; INFECTION; TRANSMISSION; DEPLETION;
D O I
10.1186/s12977-015-0187-z
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Nef is a multifunctional HIV-1 protein critical for progression to AIDS. Humans infected with nef(-) HIV-1 have greatly delayed or no disease consequences. We have contrasted nef(-) and nef(+) infection of BLT humanized mice to better characterize Nef's pathogenic effects. Results: Mice were inoculated with CCR5-tropic HIV-1(JRCSF) (JRCSF) or JRCSF with an irreversibly inactivated nef (JRCSFNefdd). In peripheral blood (PB), JRCSF exhibited high levels of viral RNA (peak viral loads of 4.71 x 10(6) +/- 1.23 x 10(6) copies/ml) and a progressive, 75% loss of CD4(+) T cells over 17 weeks. Similar losses were observed in CD4(+) T cells from bone marrow, spleen, lymph node, lung and liver but thymocytes were not significantly decreased. JRCSFNefdd also had high peak viral loads (2.31 x 10(6) +/- 1.67 x 10(6)) but induced no loss of PB CD4(+) T cells. In organs, JRCSFNefdd produced small, but significant, reductions in CD4(+) T cell levels and did not affect the level of thymocytes. Uninfected mice have low levels of HLA-DR(+)CD38(+)CD8(+) T cells in blood (1-2%). Six weeks post inoculation, JRCSF infection resulted in significantly elevated levels of activated CD8(+) T cells (6.37 +/- 1.07%). T cell activation coincided with PB CD4(+) T cell loss which suggests a common Nef-dependent mechanism. At 12 weeks, in JRCSF infected animals PB T cell activation sharply increased to 19.7 +/- 2.9% then subsided to 5.4 +/- 1.4% at 14 weeks. HLA-DR(+)CD38(+)CD8(+) T cell levels in JRCSFNefdd infected mice did not rise above 1-2% despite sustained high levels of viremia. Interestingly, we also noted that in mice engrafted with human tissue expressing a putative protective HLA-B allele (B42:01), JRCSFNefdd exhibited a substantial (200-fold) reduced viral load compared to JRCSF. Conclusions: Nef expression was necessary for both systemic T cell activation and substantial CD4(+) T cell loss from blood and tissues. JRCSFNefdd infection did not activate CD8(+) T cells or reduce the level of CD4(+) T cells in blood but did result in a small Nef-independent decrease in CD4(+) T cells in organs. These observations strongly support the conclusion that viral pathogenicity is mostly driven by Nef. We also observed for the first time substantial host-specific suppression of HIV-1 replication in a small animal infection model.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memo CD4+ T cells
    Duette, Gabriel
    Hiener, Bonnie
    Morgan, Hannah
    Mazur, Fernando G.
    Mathivanan, Vennila
    Horsburgh, Bethany A.
    Fisher, Katie
    Tong, Orion
    Lee, Eunok
    Ahn, Haelee
    Shaik, Ansari
    Fromentin, Remi
    Hoh, Rebecca
    Bacchus-Souffan, Charline
    Nasr, Najla
    Cunningham, Anthony L.
    Hunt, Peter W.
    Chomont, Nicolas
    Turville, Stuart G.
    Deeks, Steven G.
    Kelleher, Anthony D.
    Schlub, Timothy E.
    Palmer, Sarah
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (07)
  • [22] Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1
    Keppler, Oliver T.
    Tibroni, Nadine
    Venzke, Stephanie
    Rauch, Susanne
    Fackler, Oliver T.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 79 (03) : 616 - 627
  • [23] The HIV-1 Tat protein affects human CD4+ T-cell programing and activation, and favors the differentiation of naive CD4+ T cells
    Nicoli, Francesco
    Gallerani, Eleonora
    Sforza, Fabio
    Finessi, Valentina
    Chachage, Mkunde
    Geldmacher, Christof
    Cafaro, Aurelio
    Ensoli, Barbara
    Caputo, Antonella
    Gavioli, Riccardo
    AIDS, 2018, 32 (05) : 575 - 581
  • [24] Microbial exposure alters HIV-1-induced mucosal CD4+ T cell death pathways Ex vivo
    Steele, Amanda K.
    Lee, Eric J.
    Manuzak, Jennifer A.
    Dillon, Stephanie M.
    Beckham, John David
    McCarter, Martin D.
    Santiago, Mario L.
    Wilson, Cara C.
    RETROVIROLOGY, 2014, 11
  • [25] Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replication
    Guo, Haitao
    Wang, Qi
    Ghneim, Khader
    Wang, Li
    Rampanelli, Elena
    Holley-Guthrie, Elizabeth
    Cheng, Liang
    Garrido, Carolina
    Margolis, David M.
    Eller, Leigh A.
    Robb, Merlin L.
    Sekaly, Rafick-Pierre
    Chen, Xian
    Su, Lishan
    Ting, Jenny P. -Y.
    NATURE IMMUNOLOGY, 2021, 22 (04) : 423 - +
  • [27] Triple HIV-1 Infection Is Associated With Faster CD4+ T-Cell Decline
    Zhang, Yu
    Su, Bin
    Li, Hanping
    Han, Jingwan
    Zhang, Tong
    Li, Tianyi
    Wu, Hao
    Wang, Xiaolin
    Li, Jingyun
    Liu, Yongjian
    Li, Lin
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [28] HIV-1 Vpr Functions in Primary CD4+ T Cells
    Vanegas-Torres, Carlos Alberto
    Schindler, Michael
    VIRUSES-BASEL, 2024, 16 (03):
  • [29] Polyfunctional analysis of Gag and Nef specific CD8+T-cell responses in HIV-1 infected Indian individuals
    Mendiratta, Sanjay
    Vajpayee, Madhu
    Mojumdar, Kamalika
    Chauhan, Neeraj K.
    Sreenivas, Vishnubhatla
    VACCINE, 2011, 29 (06) : 1150 - 1158
  • [30] Exposure to Secreted Bacterial Factors Promotes HIV-1 Replication in CD4+ T Cells
    Znaidia, M.
    de Souza-Angelo, Y.
    Letoffe, S.
    Staropoli, I.
    Grzelak, L.
    Ghigo, J. M.
    Schwartz, O.
    Casartelli, N.
    MICROBIOLOGY SPECTRUM, 2023, 11 (02)